MarketInOut Stock Screener Log In | Sign Up

SkinBioTherapeutics Plc

LSE • Healthcare • Biotechnology • Quote as of 10/27/2026 15:59
SkinBioTherapeutics Plc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization14.9 mln
Float136 mln
Earnings Date12/02/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

0.16
Highly suspicious

Relative Strength

43 / 100
Slightly lagging

Debt / Equity

0.12
Very low leverage

Pre-Tax Margin

-9%
Marginally loss-making

ROE

-6.19
Negative

Business Description

SkinBioTherapeutics plc is a UK-based life science company that develops health products by working with the body's natural skin bacteria, known as the microbiome. Its key products include treatments aimed at speeding up wound healing, lowering infection risk, and easing the symptoms of psoriasis, with several more products in early development. The company works with Croda Plc to bring its core technology into the skincare and cosmetics industry, and sells across markets ranging from food supplements to pharmaceutical skincare. Founded in 2015 and headquartered in Driffield, UK, it operates across North America, Europe, and beyond.

Key Fundamentals

EPS-0.20
ROE-6.19
RPS0.02
ROIC-18.40
ROA-4.70
Interest Cover-8.93
EBITDA, mln0.15
EV / EBITDA88.51
EV / EBIT-38.74
Revenue, mln5.23
EV / Revenue2.56

Quote Details

Last 5.60
Change 0.07 (1.27%)
Open 5.54
Volume 145,199
Turnover 813,114
Average Volume 296,443

Financial Ratios

Pre-Tax Profit Margin-9
Leverage Ratio1.20
Current Ratio6.14
Price / Book1.94
Price / Tangible Book3.00
Debt / Equity0.12
Price / Sales3.00

Financial Strength

Altman Z-Score2.52
Piotroski F-Score 4 / 9
Beneish M-Score0.16

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.53% 32 / 100   
1 Month -6.67% 18 / 100   
2 Months -53.8% 1 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog